Page 142 - Annual report 2021-22

Annual Report 2021-22 |

NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): NOVEL PATHOGENETIC MECHANISM AND
MLP0138
THERAPEUTIC DEVELOPMENT
COMBINED DIGITAL SURVEILLANCE AND EFFECTIVE COVID-19 TESTING FRAMEWORKS AND TOOLS
MLP2003
SUBTITLE-IDENTIFYING PROGNOSTIC MARKERS IN COVID -19 PATIENTS
125
MLP2007 A LONG-TERM LONGITUDINAL OBSERVATIONAL COHORT STUDY OF HEALTH OUTCOMES
MLP2014 TRANSGENERATIONAL EFFECT OF PATERNAL AND MATERNAL VITAMIN B12 DEFICIENCY

PHENOME INDIA - A LONG-TERM LONGITUDINAL OBSERVATIONAL COHORT STUDY OF HEALTH
MLP1811
OUTCOMES
LOW LUNG-FUNCTION IN APPARENTLY HEALTHY INDIANS: PHYSIOLOGICAL VARIATION OR SUB-
GAP0124
CLINICAL DISEASE?

PREVALENCE AND PREDICTORS OF VITAMIN B12 DEFICIENCY: GENETIC ASSOCIATIONS FOR LOW
GAP0126
VITAMIN B12 LEVELS - MULTI-CENTER A PAN INDIA STUDY
GAP0146 DEPARTMENT OF BIOTECHNOLOGY- CONSORTIUM ON CELIAC DISEASE

GAP0147 SEARCH OF NOVEL PROGNOSTIC BIOMARKERS IN ACUTE DECOMPENSATED HEART FAILURE IN INDIA

HIGH RESOLUTION PLASMA PROTEOMIC AND LIPIDOMIC ANALYSIS FOR FIBROSIS RELATED METABOLIC
GAP0222 ASSESSMENT IN DIALATED CARDIOMYOPATHY (DCM) PATIENTS IN INDIA: A MULTI-CENTER BASED
STUDY

GAP0225 HYPOXIA DRIVEN ENDOTHELIAL CELL CONTROL OF VASCULAR THROMBOSIS

INTERPLAY BETWEEN UNFOLDED PROTEIN RESPONSE AND INFLAMMATORY PATHWAYS IN HYPOXIA-
GAP0226
INDUCED THROMBOEMBOLIC DISORDERS

COV-IND-UK" "PROSPECTIVE INVESTIGATION OF THE DETERMINANTS FOR COVID-19 OUTCOMES
GAP0239
AMONGST SOUTH ASIANS IN INDIA AND THE UNITED KINGDOM
MITOCHONDRIAL DYSFUNCTION IN CHILDREN DUE TO HEAT STRESS, A POTENTIAL CAUSE OF ACUTE
GAP0242
ENCEPHALITIS SYNDROME
INTEGRATED GOVERNANCE OF DIGITAL HEALTH, ARTIFICIAL INTELLIGENCE &; UHC : ACCELERATING
CLP0029
CHILD YOUTH HEALTH

CLP0031 TECHNOLOGY TOOLS FOR COVID-19 RESPONSE
CLP0034 COVID-19 FASTER TESTING AND SEQUENCING FOR RESEARCH

STANDARDIZATION OF IMMUNO - METABOLOMICS &; PROTEOMICS STUDY FROM HUMAN SAMPLE
OLP1159
COUPLING WITH SINGLE CELL DIMENSION FOR AUGMENTING IMMUNOTHERAPY

DU3 CHEMICALS AND SYSTEMS BIOLOGY

HCP0023 CSIR-SICKLE CELL ANAEMIA MISSION-PHASE II

THERAPEUTIC GENE TARGETING BY CRISPR-CAS SYSTEM: ADVANCEMENT OF EDITING PLATFORMS
MLP2009
AND PROOF-OF-CONCEPT DISEASE CORRECTION IN PATIENT DERIVED CELLS

MLP2006 MULTIPLEXED LATERAL FLOW DEVICE(S) FOR DETECTION OF COVID-19